tofidence

Roche, Biogen end patent dispute over Actemra biosimilar

Roche, Biogen end patent dispute over Actemra biosimilar

Anika Sharma

Roche has swiftly resolved a patent infringement lawsuit it initiated against Biogen in July. The legal dispute centered around Biogen’s ...

Biogen, Roche, Actemra, biosimilars, FDA approval, rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, systemic juvenile idiopathic arthritis, tofidence

FDA Approves Biogenā€™s Biosimilar, Challenging Rocheā€™s Actemra Dominance in the Market

Anika Sharma

Biogen has achieved a remarkable milestone while contemplating the future of its biosimilars division. The company proudly announced that its ...